1. Home
  2. LUNG vs PKE Comparison

LUNG vs PKE Comparison

Compare LUNG & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • PKE
  • Stock Information
  • Founded
  • LUNG 1995
  • PKE 1954
  • Country
  • LUNG United States
  • PKE United States
  • Employees
  • LUNG N/A
  • PKE N/A
  • Industry
  • LUNG Industrial Specialties
  • PKE Military/Government/Technical
  • Sector
  • LUNG Health Care
  • PKE Industrials
  • Exchange
  • LUNG Nasdaq
  • PKE Nasdaq
  • Market Cap
  • LUNG 256.3M
  • PKE 297.8M
  • IPO Year
  • LUNG 2020
  • PKE N/A
  • Fundamental
  • Price
  • LUNG $6.36
  • PKE $14.73
  • Analyst Decision
  • LUNG Buy
  • PKE
  • Analyst Count
  • LUNG 6
  • PKE 0
  • Target Price
  • LUNG $11.92
  • PKE N/A
  • AVG Volume (30 Days)
  • LUNG 214.3K
  • PKE 61.1K
  • Earning Date
  • LUNG 02-19-2025
  • PKE 01-14-2025
  • Dividend Yield
  • LUNG N/A
  • PKE 3.34%
  • EPS Growth
  • LUNG N/A
  • PKE N/A
  • EPS
  • LUNG N/A
  • PKE 0.36
  • Revenue
  • LUNG $79,302,000.00
  • PKE $61,420,000.00
  • Revenue This Year
  • LUNG $22.26
  • PKE N/A
  • Revenue Next Year
  • LUNG $18.72
  • PKE N/A
  • P/E Ratio
  • LUNG N/A
  • PKE $40.72
  • Revenue Growth
  • LUNG 22.34
  • PKE 15.45
  • 52 Week Low
  • LUNG $5.46
  • PKE $11.96
  • 52 Week High
  • LUNG $14.84
  • PKE $16.96
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.35
  • PKE 54.42
  • Support Level
  • LUNG $6.24
  • PKE $13.25
  • Resistance Level
  • LUNG $7.27
  • PKE $15.25
  • Average True Range (ATR)
  • LUNG 0.39
  • PKE 0.47
  • MACD
  • LUNG -0.06
  • PKE 0.08
  • Stochastic Oscillator
  • LUNG 2.52
  • PKE 76.47

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About PKE Park Aerospace Corp.

Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.

Share on Social Networks: